“Patents 4 Patients” Program Extended to 2022
Last week, the USPTO announced that the popular Patents for Patients pilot program will be extended an additional two years. …
Read more
USPTO Launches "Patents 4 Patients": A Cancer Immunotherapy Program
OVERVIEW The Cancer Immunotherapy Pilot Program (also known as “Patents 4 Patients”) provides accelerated review without requiring a petition fee…